At Synthego, we synthesize best-in-class gRNA enabling you to successfully perform gene editing experiments for your cell and gene therapy development. Fill out the form below to get up to 50% off your first order of 1.5, 3, 5, and 10 nmol research use only Synthetic gRNA & sgRNA.
Synthego really stands out because I'm not sure if there are many others that can offer screening scale, research use guides for your lead discovery, medium to large scale RUO guides for your preclinical and pharmacology studies, and ultimately larger scale GLP Tox and clinical grade material for early and hopefully ultimately late phase trials.
Learn more about clinical applications of CRISPR and how Synthego can support you from early-phase research, through process development, and into the clinic, highlighting our new sgRNA GMP manufacturing capabilities.
CRISPR therapies are revolutionizing medicine, making up 70% of current gene-editing trials. To accelerate the clinical development of CRISPR cell and gene therapies, Synthego has launched its new, state-of-the-art manufacturing...
This live webinar recording explores Synthego’s cutting-edge nuclease portfolio, featuring our newest engineered nuclease, eSpOT-ON. Casey Jowdy, Senior Product Manager at Synthego, dives into its development, how its on-target and...
Cart
Account
Your Orders
Sign In